Skip to main content

Advertisement

Log in

The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

This meta-analysis was performed to investigate the efficacy and safety of tranexamic acid (TXA) in the elderly patients undergoing intertrochanteric fracture surgery from the current literatures. The electronic literature database of PubMed, Embase and Cochrane library were searched in October 2019. The intraoperative blood loss, hidden blood loss, postoperative drainage and total blood loss, postoperative hemoglobin, length of stay, transfusion rate, mortality rate, thromboembolic events and wound complications were extracted. Stata 14.0 software was used for our meta-analysis. A total of 11 RCTs (3 new RCTs in 2019) with 1202 patients met our inclusion criteria. This meta-analysis showed that administration of TXA can reduce intraoperative blood loss (P = 0.009), hidden blood loss (P = 0.000), total blood loss (P = 0.000), length of stay (P = 0.003), transfusion rate (P = 0.000) and the occurrence of wound complications (P = 0.006). Furthermore, administration of TXA was associated with an increase in the postoperative Hb level at day 1, 2 and 3 (P = 0.000, P = 0.000 and P = 0.000, respectively) after surgery. However, no significant difference was found between the TXA group and control group regarding the occurrence of thromboembolic events (P = 0.978, including deep vein thrombosis, P = 0.850; pulmonary embolism, P = 0.788; cerebrovascular accident, P = 0.549; myocardial infarction, P = 0.395) and mortality rate (P = 0. 338). Our meta-analysis suggested that administration of TXA is effective in reducing intraoperative blood loss, hidden blood loss, total blood loss, length of stay, transfusion rate, wound complications and enhancing postoperative Hb without increasing the risk of thromboembolic events and mortality rate in intertrochanteric fracture surgery. More large multi-center and high-quality RCTs are required for further research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

References

  1. Ronga M, Bonzini D, Valoroso M, La Barbera G, Tamini J, Cherubino M et al (2017) Blood loss in trochanteric fractures: multivariate analysis comparing dynamic hip screw and Gamma nail. Injury 48(Suppl 3):S44–S47. https://doi.org/10.1016/S0020-1383(17)30657-5

    Article  PubMed  Google Scholar 

  2. Gullberg B, Johnell O, Kanis JA (1997) World-wide projections for hip fracture. Osteoporos Int 7:407–413

    Article  CAS  PubMed  Google Scholar 

  3. Miyamoto RG, Kaplan KM, Levine BR, Egol KA, Zuckerman JD (2008) Surgical management of hip fractures: an evidence-based review of the literature. I: femoral neck fractures. J Am Acad Orthop Surg 16:596–607

    Article  PubMed  Google Scholar 

  4. Zuckerman JD (1996) Hip fracture. N Engl J Med 334:1519–1525. https://doi.org/10.1056/NEJM199606063342307

    Article  CAS  PubMed  Google Scholar 

  5. Sheehan SE, Shyu JY, Weaver MJ, Sodickson AD, Khurana B (2015) Proximal femoral fractures: what the orthopedic surgeon wants to know. Radiographics 35:1563–1584. https://doi.org/10.1148/rg.2015140301

    Article  PubMed  Google Scholar 

  6. Panula J, Pihlajamaki H, Mattila VM, Jaatinen P, Vahlberg T, Aarnio P et al (2011) Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study. BMC Musculoskelet Disord 12:105. https://doi.org/10.1186/1471-2474-12-105

    Article  PubMed  PubMed Central  Google Scholar 

  7. Blomfeldt R, Tornkvist H, Eriksson K, Soderqvist A, Ponzer S, Tidermark J (2007) A randomised controlled trial comparing bipolar hemiarthroplasty with total hip replacement for displaced intracapsular fractures of the femoral neck in elderly patients. J Bone Joint Surg Br 89:160–165. https://doi.org/10.1302/0301-620X.89B2.18576

    Article  CAS  PubMed  Google Scholar 

  8. Foss NB, Kehlet H (2006) Hidden blood loss after surgery for hip fracture. J Bone Joint Surg Br 88:1053–1059. https://doi.org/10.1302/0301-620X.88B8.17534

    Article  CAS  PubMed  Google Scholar 

  9. Lawrence VA, Silverstein JH, Cornell JE, Pederson T, Noveck H, Carson JL (2003) Higher Hb level is associated with better early functional recovery after hip fracture repair. Transfusion 43:1717–1722. https://doi.org/10.1046/j.0041-1132.2003.00581.x

    Article  PubMed  Google Scholar 

  10. Boddaert J, Raux M, Khiami F, Riou B (2014) Perioperative management of elderly patients with hip fracture. Anesthesiology 121:1336–1341. https://doi.org/10.1097/ALN.0000000000000478

    Article  PubMed  Google Scholar 

  11. Klein HG, Spahn DR, Carson JL (2007) Red blood cell transfusion in clinical practice. Lancet 370:415–426. https://doi.org/10.1016/S0140-6736(07)61197-0

    Article  PubMed  Google Scholar 

  12. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG et al (2011) Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 365:2453–2462. https://doi.org/10.1056/NEJMoa1012452

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Hughes NT, Burd RS, Teach SJ (2014) Damage control resuscitation: permissive hypotension and massive transfusion protocols. Pediatr Emerg Care 30:651–656. https://doi.org/10.1097/PEC.0000000000000217. quiz 657–658

    Article  Google Scholar 

  14. Scully C, Robinson NA (2015) Anti-thrombotic agents. Br Dent J 219:515. https://doi.org/10.1038/sj.bdj.2015.904

    Article  CAS  PubMed  Google Scholar 

  15. Astedt B, Liedholm P, Wingerup L (1978) The effect of tranexamic acid on the fibrinolytic activity of vein walls. Ann Chir Gynaecol 67:203–205

    CAS  PubMed  Google Scholar 

  16. Zhou XD, Tao LJ, Li J, Wu LD (2013) Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials. Arch Orthop Trauma Surg 133:1017–1027. https://doi.org/10.1007/s00402-013-1761-2

    Article  PubMed  Google Scholar 

  17. Wu Q, Zhang HA, Liu SL, Meng T, Zhou X, Wang P (2015) Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trials. Eur J Orthop Surg Traumatol 25:525–541. https://doi.org/10.1007/s00590-014-1568-z

    Article  PubMed  Google Scholar 

  18. Cheriyan T, Maier SP 2nd, Bianco K, Slobodyanyuk K, Rattenni RN, Lafage V et al (2015) Efficacy of tranexamic acid on surgical bleeding in spine surgery: a meta-analysis. Spine J 15:752–761. https://doi.org/10.1016/j.spinee.2015.01.013

    Article  PubMed  Google Scholar 

  19. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. https://doi.org/10.1371/journal.pmed.1000097

    Article  PubMed  PubMed Central  Google Scholar 

  20. Higgins J (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0. In: The Cochrane Collaboration (ed) Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie 5:S38

  21. Mohib Y, Rashid RH, Ali M, Zubairi AJ, Umer M (2015) Does tranexamic acid reduce blood transfusion following surgery for inter-trochanteric fracture? A randomized control trial. J Pak Med Assoc 65:S17–20

    PubMed  Google Scholar 

  22. Baruah RK, Borah PJ, Haque R (2016) Use of tranexamic acid in dynamic hip screw plate fixation for trochanteric fractures. J Orthop Surg (Hong Kong) 24:379–382. https://doi.org/10.1177/1602400322

    Article  Google Scholar 

  23. Drakos A, Raoulis V, Karatzios K, Doxariotis N, Kontogeorgakos V, Malizos K et al (2016) Efficacy of local administration of tranexamic acid for blood salvage in patients undergoing intertrochanteric fracture surgery. J Orthop Trauma 30:409–414. https://doi.org/10.1097/BOT.0000000000000577

    Article  PubMed  Google Scholar 

  24. Tengberg PT, Foss NB, Palm H, Kallemose T, Troelsen A (2016) Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial. Bone Joint J. https://doi.org/10.1302/0301-620X.98B6.36645

    Article  PubMed  Google Scholar 

  25. Virani SR, Dahapute AA, Panda I, Bava SS (2016) Role of local infiltration of tranexamic acid in reducing blood loss in peritrochanteric fracture surgery in the elderly population. Malays Orthop J 10:26–30. https://doi.org/10.5704/MOJ.1611.013

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Lei J, Zhang B, Cong Y, Zhuang Y, Wei X, Fu Y et al (2017) Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial. J Orthop Surg Res 12:124. https://doi.org/10.1186/s13018-017-0625-9

    Article  PubMed  PubMed Central  Google Scholar 

  27. Tian S, Shen Z, Liu Y, Zhang Y, Peng A (2018) The effect of tranexamic acid on hidden bleeding in older intertrochanteric fracture patients treated with PFNA. Injury 49:680–684. https://doi.org/10.1016/j.injury.2018.01.026

    Article  PubMed  Google Scholar 

  28. Schiavone A, Bisaccia M, Inkov I, Rinonapoli G, Manni M, Rollo G et al (2018) Tranexamic acid in pertrochanteric femoral fracture: is it a safe drug or not? Folia Med (Plovdiv) 60:67–78. https://doi.org/10.1515/folmed-2017-0070

    Article  CAS  Google Scholar 

  29. Luo X, He S, Lin Z, Li Z, Huang C, Li Q (2019) Efficacy and safety of tranexamic acid for controlling bleeding during surgical treatment of intertrochanteric fragility fracture with proximal femoral nail anti-rotation: a randomized controlled trial. Indian J Orthop 53:263–269. https://doi.org/10.4103/ortho.IJOrtho_401_17

    Article  PubMed  PubMed Central  Google Scholar 

  30. Zhou XD, Zhang Y, Jiang LF, Zhang JJ, Zhou D, Wu LD et al (2019) Efficacy and safety of tranexamic acid in intertrochanteric fractures: a single-blind randomized controlled trial. Orthop Surg 11:635–642. https://doi.org/10.1111/os.12511

    Article  PubMed  PubMed Central  Google Scholar 

  31. Chen F, Jiang Z, Li M, Zhu X (2019) Efficacy and safety of perioperative tranexamic acid in elderly patients undergoing trochanteric fracture surgery: a randomised controlled trial. Hong Kong Med J 25:120–126. https://doi.org/10.12809/hkmj187570

    Article  CAS  PubMed  Google Scholar 

  32. Dhanwal DK, Dennison EM, Harvey NC, Cooper C (2011) Epidemiology of hip fracture: worldwide geographic variation. Indian J Orthop 45:15–22. https://doi.org/10.4103/0019-5413.73656

    Article  PubMed  PubMed Central  Google Scholar 

  33. Moran CG, Wenn RT, Sikand M, Taylor AM (2005) Early mortality after hip fracture: is delay before surgery important? J Bone Joint Surg Am 87:483–489. https://doi.org/10.2106/JBJS.D.01796

    Article  PubMed  Google Scholar 

  34. Yang ZG, Chen WP, Wu LD (2012) Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am 94:1153–1159. https://doi.org/10.2106/JBJS.K.00873

    Article  PubMed  Google Scholar 

  35. Zhou XD, Li J, Fan GM, Huang Y, Xu NW (2019) Efficacy and safety of tranexamic acid in elderly patients with intertrochanteric fracture: an updated meta-analysis. World J Clin Cases 7:1302–1314. https://doi.org/10.12998/wjcc.v7.i11.1302

    Article  PubMed  PubMed Central  Google Scholar 

  36. Watts CD, Houdek MT, Sems SA, Cross WW, Pagnano MW (2017) Tranexamic acid safely reduced blood loss in hemi- and total hip arthroplasty for acute femoral neck fracture: a randomized clinical trial. J Orthop Trauma 31:345–351. https://doi.org/10.1097/BOT.0000000000000837

    Article  PubMed  Google Scholar 

  37. Gao F, Sun W, Guo W, Li Z, Wang W, Cheng L (2015) Topical administration of tranexamic acid plus diluted-epinephrine in primary total knee arthroplasty: a randomized double-blinded controlled trial. J Arthroplasty 30:1354–1358. https://doi.org/10.1016/j.arth.2015.03.003

    Article  PubMed  Google Scholar 

  38. Jiang W, Shang L (2019) Tranexamic acid can reduce blood loss in patients undergoing intertrochanteric fracture surgery: a meta-analysis. Medicine (Baltimore) 98:e14564. https://doi.org/10.1097/MD.0000000000014564

    Article  CAS  Google Scholar 

  39. Zufferey PJ, Miquet M, Quenet S, Martin P, Adam P, Albaladejo P et al (2010) Tranexamic acid in hip fracture surgery: a randomized controlled trial. Br J Anaesth 104:23–30. https://doi.org/10.1093/bja/aep314

    Article  CAS  PubMed  Google Scholar 

  40. Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M et al (2014) Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ 349:g4829. https://doi.org/10.1136/bmj.g4829

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wenhao Zheng.

Ethics declarations

Conflicts of interest

All authors declare that they have no conflict of interest.

Ethical approval

All analyses were based on previous published studies; thus, no ethical approval is required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 1407 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yu, X., Wang, J., Wang, X. et al. The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials. J Thromb Thrombolysis 50, 243–257 (2020). https://doi.org/10.1007/s11239-019-02034-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-019-02034-1

Keywords

Navigation